Market Report / Israeli stocks set two-and-a-half-year high
Teva buoyed by success of late-stage clinical trial to treat multiple sclerosis.
The Tel Aviv Stock Exchange closed at a two-and-a-half-year high Sunday, making up losses incurred Thursday when index compositions were rebalanced. Shares were pulled up by optimism and arbitrage gaps that opened over the weekend.
register with haaretz
Like us on Facebook and get articles directly in your news feed